Associations Between the Phosphatidylethanol Alcohol Biomarker and Self-Reported Alcohol Use in a Sample of HIV-Infected Outpatient Drinkers in Western Kenya
Background To counteract the syndemics of HIV and alcohol in Sub‐Saharan Africa, international collaborations have developed interventions to reduce alcohol consumption. Reliable and accurate methods are needed to estimate alcohol use outcomes. A direct alcohol biomarker called phosphatidylethanol (...
Saved in:
| Published in: | Alcoholism, clinical and experimental research Vol. 40; no. 8; pp. 1779 - 1787 |
|---|---|
| Main Authors: | , , , , , , , , , , , |
| Format: | Journal Article |
| Language: | English |
| Published: |
England
Blackwell Publishing Ltd
01-08-2016
Wiley Subscription Services, Inc |
| Subjects: | |
| Online Access: | Get full text |
| Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
| Summary: | Background
To counteract the syndemics of HIV and alcohol in Sub‐Saharan Africa, international collaborations have developed interventions to reduce alcohol consumption. Reliable and accurate methods are needed to estimate alcohol use outcomes. A direct alcohol biomarker called phosphatidylethanol (PEth) has been shown to validate heavy, daily drinking, but the literature indicates mixed results for moderate and nondaily drinkers, including among HIV‐infected populations. This study examined the associations of the PEth biomarker with self‐report alcohol use at 2 time points in 127 HIV‐infected outpatient drinkers in western Kenya.
Methods
Participants were consecutively enrolled in a randomized clinical trial to test the efficacy of a behavioral intervention to reduce alcohol use in Eldoret, Kenya. They endorsed current alcohol use, and a minimum score of 3 on the Alcohol Use Disorders Identification Test‐Consumption or consuming ≥6 drinks per occasion at least monthly in the past year. Study interviews and blood draws were conducted at baseline and at 3 months post treatment from July 2012 through September 2013. Alcohol use was assessed using the Timeline Followback questionnaire. Blood samples were analyzed for the presence of the PEth biomarker and were compared to self‐reported alcohol use. We also conducted semistructured interviews with 14 study completers in February through March 2014.
Results
Baseline data indicated an average of moderate–heavy alcohol use: 50% drinking days and a median of 4.5 drinks per drinking day. At baseline, 46% of women (31 of 67) and 8% of men (5 of 60) tested negative for PEth (p < 0.001). At the 3‐month follow‐up, 93% of women (25 of 27) and 97% of men (30 of 31) who reported drinking tested positive, while 70% of women (28 of 40) and 35% of men (10 of 29) who denied drinking tested negative for PEth. Interviews were consistent with self‐reported alcohol use among 13 individuals with negative baseline results.
Conclusions
These results add to the growing literature showing lack of agreement between self‐report and PEth results among unhealthy and nondaily drinkers, particularly women. More research is needed to determine at what level of consumption over what period of time PEth becomes a reliable and accurate indicator of alcohol use.
A direct alcohol biomarker called phosphatidylethanol (PEth) has been shown to validate heavy, daily drinking, but indicates mixed results for moderate and nondaily drinkers. We compared PEth results to self‐report among 127 HIV‐infected drinkers in western Kenya indicating moderate–heavy nondaily alcohol use using the Timeline Followback. Agreement between self‐report and PEth levels was better among men than women and at second of 2 study time points. Thirteen interviews among study completers with negative PEth baseline results showed consistency with self‐report. |
|---|---|
| Bibliography: | U.S. National Institute on Alcohol Abuse and Alcoholism (NIAAA) - No. R01AA020805; No. 2K05 16928 istex:830C017A07F5E7E69B0F430017127B22CA8C4897 United States Agency for International Development as part of the President's Emergency Plan for AIDS Relief ark:/67375/WNG-FV530VZ6-Z ArticleID:ACER13132 ObjectType-Article-1 SourceType-Scholarly Journals-1 ObjectType-News-2 ObjectType-Feature-3 content type line 23 ObjectType-Feature-2 |
| ISSN: | 0145-6008 1530-0277 |
| DOI: | 10.1111/acer.13132 |